This review addresses contemporary mucoadhesive drug delivery systems. The use of hydrophilic polymers increases the retention time of the delivery system on mucosal tissues, leading to the gradual release of the active ingredient and better tolerance by the patient. The mucoadhesive interaction is explained in relation to the structural characteristics of mucosal tissues and the properties of the polymers. A separate section addresses the advantages and disadvantages of various mucoadhesive drug delivery systems (tablets, films, gels, microcapsules, and nanocarriers) and developed and commercially available medicinal formulations based on mucoadhesive polymers.
Similar content being viewed by others
References
R. Birudaraj, R. Mahalingam, X. Li, and B. R. Jasti, Crit. Rev. Ther. Drug Carrier Syst., 3(22), 295 – 330 (2005).
Z. Cui and R. J. Mumper, Pharm. Res., 19(12), 1901 – 1906 (2002).
E. Gavini, G. Rassu, M. Cossu, and P. Giunchedi, J. Pharm. Phamacol., 57(3), 287 – 294 (2005).
H. E. Junginger, J. A. Hoogstraate, and J. C. Verhoef, J. Contr. Rel., 62(1 – 2), 149 – 159 (1999).
G. Ponchel and J.-M. Irache, Adv. Drug. Del. Rev., 34(2 – 3), 191 – 219 (1998).
N. Salamat-Miller, M. Chittchang, and T. P. Johnston, Adv. Drug. Del. Rev., 57(11), 1666 – 1691 (2005).
M. I. Ugwoke, R. U. Agu, N. Verbeke, and R. Kinget, Adv. Drug. Del. Rev., 57(11), 1640 – 1665 (2005).
J. K. Vasir, K. Tambwekar, and S. Garg, Int. J. Pharm., 255(1 – 2), 13 – 32 (2003).
A. Ahuja, J. Ali, and S. Rahman, Pharmazie, 61(1), 25–29 (2006).
H. Batchelor, The Drug Delivery Companies Report: Autumn / Winter 2004, 16 – 19, (2004).
I. Genta, B. Conti, P. Perugini, et al., J. Pharm. Pharmacol., 49(8), 737 – 742 (1997).
H. Okamoto, H. Taguchi, K. Iida, and K. Danjo, J. Contr. Rel., 77(3), 253 – 260 (2001).
J. Van Roey, M. Haxaire, M. Kamya, et al., J. Acquir. Immune Defic. Syndr., 35(2), 144 – 150 (2004).
K. Park and J. R. Robinson, Int. J. Pharm., 198, 107 – 127 (1984).
L. Illum, J. Contr. Rel., 87(1 – 3), 187 – 198 (2003).
A. Ludwig, Adv. Drug. Del. Rev., 57(11), 1595 – 1639 (2005).
N. A. Peppas and J. J. Sahlin, Biomaterials, 17(16), 1553 – 1561 (1996).
A Ham and D. Cormack, Histology [Russian translation], Mir, Moscow (2006).
C. Valenta, Adv. Drug. Del. Rev., 57(11), 1692 – 1712 (2005).
D. A. Pecosky and J. R. Robinson, in: Polymers for Controlled Drug Delivery, P. J. Tarcha (Ed.), CRC Press, Boca Raton, Ann Arbor, Boston (1991), pp. 99 – 125.
N. A. Peppas, TUFTAD Haberler (Special Issue), 4 – 8 (2005).
A. H. Kutscher, E. V. Zegarelli, F. E. Beube, et al., Oral Surg. Oral Med. Oral Pathol., 12, 1080 – 1089 (1959).
H. Batchelor, CRS Newsletter, 22(1), 4 – 5 (2005).
V. Grabovac, D. Guggi, and A. Bernkop-Schnurch, Adv. Drug. Del. Rev., 57(11), 1713 – 1723 (2005).
J. D. Smart, Adv. Drug. Del. Rev., 57(11), 1556 – 1568 (2005).
S. A. Agnihotri, N. N. Mallikarjuna, and T. M. Aminabhavi, J. Contr. Rel., 100(1), 5 – 28 (2004).
J. Berger, M. Reist, J. M. Mayer, et al., Eur. J. Pharm. Biopharm., 57(1), 19 – 34 (2004).
P. Calvo, C. Remunan-Lopez, J. L. Vila-Jato, and M. J. Alonso, Pharm. Res., 14(10), 1431 – 1436 (1997).
A. M. De Campos, A. Sanchez, and M. J. Alonso, Int. J. Pharm., 224(1 – 2), 159 – 168 (2001).
O. Felt, J. M. Mayer, P. Furrer, et al., Int. J. Pharm., 180(2), 185 – 193 (1999).
C. Bies, C.-M. Lehr, and J. F. Woodley, Adv. Drug. Del. Rev., 56(4), 425 – 435 (2004).
B. V. Deryaguin, Y. P. Toporov, V. M. Mueler, and I. N. Aleinikova, J. Colloid Interface Sci., 58, 528 – 533 (1977).
W. C. Wake, Adhesion and the Formulation of Adhesives, Applied Science, London (1982), pp. 67 – 119.
E. Helfand and Y. Tagami, J. Chem. Phys., 57, 1812 – 1813 (1972).
Y. Huang,W. Leobandung, A. Foss, and N. A. Peppas, J. Contr. Rel., 65(1 – 2), 63 – 71 (2000).
H. R. Costantino, L. Illum, G. Brandt, et al., Int. J. Pharm., 337(1 – 2), 1–24 (2007).
H. Critchley, S. S. Davis, N. F. Farraj, and L. Illum, J. Pharm. Phamacol., 46(8), 651 – 656 (1994).
L. Illum, N. F. Farraj, A. N. Fisher, et al., J. Contr. Rel., 29, 133 – 141 (1994).
M. Koping-Hoggard, A. Sanchez, and M. J. Alonso, Expert Rev. Vaccines, 4(2), 185 – 196 (2005).
L. Illum, J. Aerosol Med., 19(1), 92 – 99 (2006).
J. W. Lee, J. H. Park, and J. R. Robinson, J. Pharm. Sci., 89(7), 850 – 866 (2000).
P. Duclos, Vaccine, 22(15 – 16), 2059 – 2063 (2004).
L. Jodar, P. Duclos, J. B. Milstien, et al., Vaccine, 19(13 – 14), 1594 – 1605 (2001).
D. T. O’Hagan and R. Rappuoli, Pharm. Res., 21(9), 1519 – 1530 (2004).
E. C. Lavelle and D. T. O’Hagan, Expert Opin. Drug Deliv., 3(6), 747 – 762 (2006).
S. Trolle, A. Andremont, and E. Fattal, STP Pharma Sciences, 8(1), 19 – 30 (1998).
R. C. Read, S. C. Naylor, C. W. Potter, et al., Vaccine, 23(35), 4367 – 4374 (2005).
K. H. Mills, C. Cosgrove, E. A. McNeela, et al., Infect. Immun., 71(2), 726 – 732 (2003).
Th. F. Vandamme and L. Brobeck, J. Contr. Rel., 102(1), 23 – 38 (2005).
N. B. Chesnokova, Dissertation for Doctorate in Biological Sciences [in Russian], Moscow (1991).
US Patent No. 6248358 (2001).
N. A. Nafee, F. A. Ismail, N. A. Boraie, and L. M. Mortada, Drug Dev. Ind. Pharm., 30(9), 995 – 1004 (2004).
M. K. Chun, B. T. Kwak, and H. K. Choi, Arch. Pharm. Res., 26(11), 973 – 978 (2003).
S. F. Huang, J. L. Chen, M. K. Yeh, and C. H. Chiang, J. Ocul. Pharmacol. Ther., 21(6), 445 – 453 (2005).
S. Rossi, G. Sandri, F. Ferrari, et al., Pharm. Dev. Technol., 8(2), 199 – 208 (2003).
The British pharmacopoeia 1948, The General Council of Medical and Registration of the United Kingdom, London (1948).
US Patent No. 3828777 (1974).
P. Sihvola and T. Puustjarvi, Acta Ophthalmol. (Copenh.), 58(6), 933 – 937 (1980).
Yu. F. Maichuk, Ocular Therapeutic Films [in Russian], Meditsina, Moscow (1986).
N. I. Larionova, N. A. Moroz, N. G. Balabushevich, et al., Vestnik Mosk. Gos. Univ. Ser. 2. Khimiya, 36(2), 139 – 145 (1995).
C. Li, P. P. Bhatt, and T. P. Johnston, Pharm. Dev. Technol., 2(3), 265 – 274 (1997).
S. Jay, W. Fountain, Z. Cui, and R. J. Mumper, J. Pharm. Sci., 91(9), 2016 – 2025 (2002).
V. I. Metelitsa and A. B. Davydov, Ter. Arkhiv, 5, 54 – 59 (1980).
R. Arshady (Ed.), Microspheres, Microcapsules and Liposomes, MML Series, Vol. 1–5, Citus Books Ltd., London (1999 – 2002).
V. D. Solodovnik, Microencapsulation [in Russian], Khimiya, Moscow (1980).
Z. Liu, W. Lu, L. Qian, et al., J. Contr. Rel., 102(1), 135 – 144 (2005).
H. Takeuchi, H. Yamamoto, and Y. Kawashima, Adv. Drug. Del. Rev., 47(1), 39 – 54 (2001).
J. Albietz, G. Napper, and I. Douglas, Clin. Exp. Optom., 86(2), 131 – 132 (2003).
A. Preetha and R. Banerjee, Trends Biomater. Artif. Organs, 18(2), 178 – 186 (2005).
A. M. Potts, S. Jackson, N.Washington, et al., Proc. of 24th Int. Symp. Control. Release Bioact. Mater., Stockholm, Sweden (1997), pp. 335 – 336.
US Patent No. 6432440 (2002).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 43, No. 4, pp. 21 – 29, April, 2009.
Rights and permissions
About this article
Cite this article
Kharenko, E.A., Larionova, N.I. & Demina, N.B. Mucoadhesive drug delivery systems (Review). Pharm Chem J 43, 200–208 (2009). https://doi.org/10.1007/s11094-009-0271-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-009-0271-6